{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:47:57Z","timestamp":1758991677250},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T00:00:00Z","timestamp":1147305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,22]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Leishmania infantum is the causative agent of zoonotic visceral leishmaniasis (VL). If untreated the disease could be fatal; however, in some cases the infection can run a subclinical course. In subclinical infections a Th1-response predominates, while Th2-responses and\/or probably Treg cells are related to unfavourable outcome of the disease in active VL. In the present study we determined the levels of soluble (s) CD26 and CD30 co-stimulatory molecules in sera from patients with active VL, asymptomatic individuals and healthy volunteers. Results showed a significant difference in both sCD26 and sCD30 between infected cases and normal individuals (P\u2003\u2264\u20030\u00b7001). However, there was no significant difference in sCD26 levels between asymptomatic cases and patients, although the difference was not significant. sCD30 levels were significantly higher in VL patients than asymptomatic cases (P\u2003\u2264\u20030\u00b7001). These findings suggest a possible association between sCD26 and sCD30 levels and the clinical manifestation of L. infantum infection.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2006.03105.x","type":"journal-article","created":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T15:31:25Z","timestamp":1147361485000},"page":"44-47","source":"Crossref","is-referenced-by-count":12,"title":["Soluble CD26\/CD30 levels in visceral leishmaniasis: markers of disease activity"],"prefix":"10.1093","volume":"145","author":[{"given":"S","family":"Ajdary","sequence":"first","affiliation":[{"name":"Immunology Department, Pasteur Institute of Iran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Riazi-Rad","sequence":"additional","affiliation":[{"name":"Immunology Department, Pasteur Institute of Iran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Jafari-Shakib","sequence":"additional","affiliation":[{"name":"Gilan University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mohebbali","sequence":"additional","affiliation":[{"name":"School of Public Health, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,5,11]]},"reference":[{"key":"2022010506333154100_b1","first-page":"238","article-title":"An endemic focus of visceral leishmaniasis in Meshkin-Shahr, East Azerbaijan province, North-West part of Iran and IFA serological survey of the disease in the area","volume":"81","author":"Edrissian","year":"1988","journal-title":"Bull Soc Pathol Exot"},{"key":"2022010506333154100_b2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0031182099004680","article-title":"Age acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran","volume":"119","author":"Davies","year":"1999","journal-title":"Parasitology"},{"key":"2022010506333154100_b3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4269\/ajtmh.1985.34.1069","article-title":"Epidemiological study of visceral leishmaniasis in Honduras, 1975\u201383","volume":"34","author":"Navin","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"2022010506333154100_b4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/infdis\/154.6.1003","article-title":"New perspectives on a subclinical form of visceral leishmaniasis","volume":"154","author":"Badaro","year":"1986","journal-title":"J Infect Dis"},{"key":"2022010506333154100_b5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/165.3.535","article-title":"Immunologic markers of clinical evolution in children recently infected with Leishmania donovani Chagasi","volume":"165","author":"Carvalho","year":"1992","journal-title":"J Infect Dis"},{"key":"2022010506333154100_b6","doi-asserted-by":"crossref","first-page":"55559","DOI":"10.1128\/IAI.67.11.5559-5566.1999","article-title":"Control of leishmania infantum infection is associated with CD8 and gamma-interferon and IL-5-producing CD4 antigen-specific T cells","volume":"67","author":"Mary","year":"1999","journal-title":"Infect Immun"},{"key":"2022010506333154100_b7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/517817","article-title":"Splenic cytokine response in Indian kala-azar before and after treatment","volume":"177","author":"Kenney","year":"1998","journal-title":"J Infect Dis"},{"key":"2022010506333154100_b8","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","article-title":"Restoration of IFN-\u03b3 production and lymphocyte proliferation in visceral leishmaniasis","volume":"152","author":"Carvalho","year":"1994","journal-title":"J Immunol"},{"key":"2022010506333154100_b9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1006\/cyto.1995.0088","article-title":"In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis","volume":"7","author":"Cillari","year":"1995","journal-title":"Cytokine"},{"key":"2022010506333154100_b10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0090-1229(90)90038-R","article-title":"Determinants of the immune response in visceral leishmaniasis: evidence of predominance of endogenous interleukin-4 over interferon-\u03b3 production","volume":"57","author":"Zwingenberger","year":"1990","journal-title":"Clin Immunol Immunopath"},{"key":"2022010506333154100_b11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin-10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"Ghalib","year":"1993","journal-title":"J Clin Invest"},{"key":"2022010506333154100_b12","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1172\/JCI116878","article-title":"Potential role for interleukin-10 in the immunosuppression associated with kala azar","volume":"92","author":"Holaday","year":"1993","journal-title":"J Clin Invest"},{"key":"2022010506333154100_b13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2249.1998.00468.x","article-title":"High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis","volume":"111","author":"Gasim","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"2022010506333154100_b14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0105-2896.2004.00185.x","article-title":"Re-examination of the immunosuppressive mechanisms mediating non-cure of leishmania infection in mice","volume":"201","author":"Sacks","year":"2004","journal-title":"Immunol Rev"},{"key":"2022010506333154100_b15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1096\/fasebj.9.1.7821763","article-title":"Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokine","volume":"9","author":"Del Prete","year":"1995","journal-title":"FASEB J"},{"key":"2022010506333154100_b16","first-page":"685","article-title":"CD26 expression in leprosy and other granulomatous diseases correlation with the production of IFN-\u03b3","volume":"73","author":"Scheel-Toelner","year":"1995","journal-title":"Lab Invest"},{"key":"2022010506333154100_b17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0091-6749(97)70248-3","article-title":"Cell surface characterization of T lymphocyte and allergen-specific T cell clones: correlation of CD26 expression with Th1 subsets","volume":"100","author":"Willheim","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"2022010506333154100_b18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1006\/cyto.1999.0643","article-title":"Mechanisms of CD26\/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes","volume":"12","author":"Salgado","year":"2000","journal-title":"Cytokine"},{"key":"2022010506333154100_b19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2249.2000.01286.x","article-title":"Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26","volume":"121","author":"Katoh","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022010506333154100_b20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1006\/cyto.1999.0653","article-title":"Soluble CD30 serum level in HCV-positive chronic active hepatitis: a surrogate marker of disease activity?","volume":"12","author":"Foschi","year":"2000","journal-title":"Cytokine"},{"key":"2022010506333154100_b21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2249.1996.915607.x","article-title":"Serum level CD30 in chronic hepatitis B virus infection","volume":"103","author":"Fattovich","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2022010506333154100_b22","first-page":"1858","article-title":"Reduction of serum soluble CD26\/dipeptidyl IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus","volume":"29","author":"Kobayashi","year":"2002","journal-title":"J Rheumatol"},{"key":"2022010506333154100_b23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4 CD25 regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid y Piccirillo","year":"2002","journal-title":"Nature"},{"key":"2022010506333154100_b24","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of IL-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J Exp Med"},{"key":"2022010506333154100_b25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J Immunol"},{"key":"2022010506333154100_b26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/clin.1996.0118","article-title":"Th1 and Th2 in human disease","volume":"80","author":"Romagnani","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"2022010506333154100_b27","first-page":"667","article-title":"Th-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (Scd30)","volume":"280","author":"De Pita","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"2022010506333154100_b28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2249.2004.02570.x","article-title":"Interleukin-16 expression and release in bullous pemphigoid","volume":"137","author":"Frezzolini","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2022010506333154100_b29","first-page":"67","article-title":"Soluble CD26\/30 levels before and after treatment with IFN-\u03b1 and ribavirin combination therapy in a pediatric hepatitis C patient","volume":"37","author":"Liao","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"2022010506333154100_b30","first-page":"457","article-title":"Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides","volume":"18","author":"Schonermarck","year":"2000","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2006.03105.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/145\/1\/44\/42072208\/j.1365-2249.2006.03105.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/145\/1\/44\/42072208\/j.1365-2249.2006.03105.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T11:34:30Z","timestamp":1683459270000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/145\/1\/44\/6458730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,5,11]]},"published-print":{"date-parts":[[2006,5,22]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03105.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,5,11]]}}}